User Satisfaction of an Instrumented Standing Frame

Sponsor
University of Southern Denmark (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06033885
Collaborator
R82 A/S (Other), Innovation Fund Denmark (Other)
15
1
1
11
1.4

Study Details

Study Description

Brief Summary

Standing frames have existed for a long time and are well-established medical devices used to allow weight bearing in standing for persons who are unable to stand independently.

Documenting the effectiveness of interventions using standing frames is complex. The current evidence base for their use is limited due to studies of low to moderate quality and small effects documented.

Providing real-time feed-back on force and position and thus continuous tracking of the intensity allows for informed decision making about the support provided by the standing frame in clinical settings, thereby making it possible to document the potential setup for optimal support and potential association between the intensity and positive effects of the standing frames.

The objective of the study is to document potential short-term benefits on a) patient satisfaction and health-related quality of life and b) changes in prescription from the prescribing therapist of the use of standing frames in children with standing disabilities when PONDUS®, a digital product used to assess the force applied during standing in a R82 standing frame is applied opposed to current practice.

The study is a one-arm feasibility intervention study using participants as their own controls. The study will include 15 children with functional disabilities who currently uses a standing frame.

Condition or Disease Intervention/Treatment Phase
  • Device: PONDUS®
N/A

Detailed Description

Most children stand independently by the age of 11 month, allowing them to apply different loads on their bones, joints, and muscles, and experience their surroundings from a new perspective (1-2). Children who do not reach the motor milestone "standing" in early childhood should have access to assistive medical devices such as standing frames, which enable them to gain benefits of the standing position as typically developing children (3).

Standing frames have existed for a long time and are well-established medical devices used to allow weight bearing in standing for persons who are unable to stand independently. The frame supports the child with upholstered plates and straps around the legs, trunk and/or head and is often positioned in an almost vertical posture, allowing the user partial weight bearing on their lower extremities. The devices are widely used as part of postural management for persons with disability (4-5) and a population-based study in Sweden shows that 31% of all children with cerebral palsy use external support to stand (6).

Documenting the effectiveness of interventions using standing frames is complex. The current evidence base for their use is limited due to studies of low to moderate quality and small effects documented (5, 7, 8-17). A systematic review (5) and recent studies on the potential benefits of using standing frames indicate improvements in a range of functions and activities including: mental functions (7), bone and joint development and health (8-12), cardiovascular and respiratory systems, digestive systems and urinary functions (7-8), neuromusculoskeletal and movement related functions, pain (7-8), mobility (13), the ability to maintain a sitting or standing position (14-16), and major life areas, including interaction with peers (5, 17). Importantly, the studies did not report adverse events or serious harm.

The above studies reveal a large variety in dosing in terms of frequency and time of use of the standing frames from <1 to 7 days per week, 1 or more sessions per day and <30 min to

120 min per session (5). Importantly, none of the studies document dosing in terms of intensity assessed as the degree of weight bearing while using a standing frame. Multiple variables such as type of frame, use of supports, inclination, activities performed while standing and inclination of the frame have been suggested to affect weight bearing in standing frames (18). Instrumented standing frames have been used in experimental settings and have documented a large variation in percentage of body weight from 23-133%, which could indicate serious issues of controlling the intensity or even misuse and/or measurement error (18-20). To our knowledge, instrumented standing frames that can assess force and position during the use of a standing frames is currently not available for use in clinical practice.

The lack of information about force and position during the use of standing frames in clinical settings makes it impossible to document the potential setup for optimal support and potential association between the intensity and positive effects of the standing frames and, moreover, whether the intensity of the intervention should be tailored to the individual child.

Providing real-time feed-back on force and position and thus continuous tracking of the intensity allows for informed decision making about the support provided by the standing frame in a clinical setting.

The purpose of this study is to document potential short-term benefits on a) patient satisfaction and health-related quality of life and b) changes in prescription from the prescribing therapist of the use of standing frames in children with standing disabilities when PONDUS®, a digital product used to assess the force applied during standing in a R82 standing frame, is applied opposed to current practice.

The study is a one-arm feasibility intervention study using participants as their own controls. The study will be conducted in special day-care centers and schools or in the children's home. Participants will be 15 children with functional disabilities in the age of 3-17 years who currently uses a standing frame.

Recruitment will be conducted in collaboration with the study's commercial partner's distributor network and special day-care centers and schools across Denmark, that will assist in identifying possible study participants. In addition to the above parents will be reached through advocacy organizations or on social medias with an invitation for participation in the studies.

Prior to the intervention a 4-week control period, where the non-instrumented standing frame is used according to standard practice, will be carried out. Subsequently, a 4-week intervention period, where the standing frame is instrumented (PONDUS®) allowing continued monitoring and adjustments of the force and position during sessions will be conducted. Changes in outcome measures will be evaluated as the difference in within-group change score between the control period and intervention period.

Participation in the study will be voluntary and all participants will be informed that even after the eventual acceptance of participation, at any stage of the project they may decide to discontinue participation in the trial without giving any reason and without it having consequences for further treatment.

  1. WHO Multicentre Growth Reference Study (2006) WHO Motor Development Study: Windows of achievement for six gross motor development milestones, Acta Paediatrica, 2006; Suppl. 450:86-95.

  2. Wijnhovet et al (2004) Assessment of gross motor development in the WHO Multicentre Growth Reference Study, Food and Nutrition Bulletin 25,1 (supp. 1)

  3. WHO Early childhood development and disability Early childhood development and disability: discussion paper. ISBN 9789241504065

  4. Goodwin J, Lecouturier J, Smith J, Crombie S, Basu A, Parr JR, Howel D, McColl E, Roberts A, Miller K, Cadwgan J. Understanding frames: A qualitative exploration of standing frame use for young people with cerebral palsy in educational settings. Child Care Health Dev. 2019 May;45(3):433-439. doi: 10.1111/cch.12659.

  5. Paleg GS, Smith BA, Glickman LB. Systematic review and evidence-based clinical recommendations for dosing of pediatric supported standing programs. Pediatr Phys Ther. 2013 Fall;25(3):232-47. doi: 10.1097/PEP.0b013e318299d5e7.

  6. Rodby-Bousquet E, Hägglund G. Sitting and standing performance in a total population of children with cerebral palsy: a cross-sectional study. BMC Musculoskelet Disord. 2010;11:131. Published 2010 Jun 23. Doi:10.1186/1471-2474-11-131

  7. Rivi E, Filippi M, Fornasari E, Mascia MT, Ferrari A, Costi S. Effectiveness of standing frame on constipation in children with cerebral palsy: a single-subject study. Occup Ther Int. 2014 Sep;21(3):115-23. doi: 10.1002/oti.1370.

  8. Capati V, Covert SY, Paleg G. Stander use for an adolescent with cerebral palsy at GMFCS level V with hip and knee contractures. Assist Technol. 2019 Apr 4:1-7. doi: 10.1080/10400435.2019.1579268.

  9. Han EY, Choi JH, Kim SH, Im SH. The effect of weight bearing on bone mineral density and bone growth in children with cerebral palsy: A randomized controlled preliminary trial. Medicine (Baltimore). 2017 Mar;96(10):e5896. doi: 10.1097/MD.0000000000005896.

  10. Macias-Merlo L, Bagur-Calafat C, Girabent-Farrés M, A Stuberg W. Effects of the standing program with hip abduction on hip acetabular development in children with spastic diplegia cerebral palsy. Disabil Rehabil. 2016;38(11):1075-81. doi: 0.3109/09638288.2015.1100221.

  11. Macias-Merlo L, Bagur-Calafat C, Girabent-Farrés M, Stuberg WA. Standing Programs to Promote Hip Flexibility in Children With Spastic Diplegic Cerebral Palsy. Pediatr Phys Ther. 2015 Fall;27(3):243-9. doi: 10.1097/PEP.0000000000000150.

  12. Hough JP, Boyd RN, Keating JL. Systematic review of interventions for low bone mineral density in children with cerebral palsy. Pediatrics. 2010;125(3):e670-e678. Doi:10.1542/peds.2009-0292

  13. Salem Y, Lovelace-Chandler V, Zabel RJ, McMillan AG. Effects of prolonged standing on gait in children with spastic cerebral palsy. Phys Occup Ther Pediatr. 2010;30(1):54-65. doi:10.3109/01942630903297177

  14. Curtis DJ, Woollacott M, Bencke J, et al. The functional effect of segmental trunk and head control training in moderate-to-severe cerebral palsy: A randomized controlled trial. Dev Neurorehabil. 2018;21(2):91-100. Doi:10.1080/17518423.2016.1265603

  15. Curtis DJ, Butler P, Saavedra S, et al. The central role of trunk control in the gross motor function of children with cerebral palsy: a retrospective cross-sectional study. Dev Med Child Neurol. 2015;57(4):351-357. Doi:10.1111/dmcn.12641.

  16. George F, A case series exploring static and dynamic posture: how making static equipment dynamic may improve movement and function of children with neurological impairment. APCP Journal 2018;9:56-63

  17. Pedlow_K, McDonough_S, Lennon_S, Kerr_C, Bradbury_I. Assisted standing for Duchenne muscular dystrophy. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD011550. DOI: 10.1002/14651858.CD011550.pub2.

  18. Paleg G, Altizer W, Malone R, Ballard K, Kreger A. Inclination, hip abduction, orientation, and tone affect weight-bearing in standing devices. J Pediatr Rehabil Med. 2021 May 28. doi: 10.3233/PRM-190660. Epub ahead of print. PMID: 34057103.

  19. Herman D, May R, Vogel L, Johnson J, Henderson RC. Quantifying weight-bearing by children with cerebral palsy while in passive standers. Pediatr Phys Ther 2007;19:283-7

  20. Kecskemethy HH, Herman D, May R, Paul K, Bachrach SJ, Henderson RC. Quantifying weight bearing while in passive standers and a comparison of standers. Dev Med Child Neurol. 2008 Jul;50(7):520-3. doi: 10.1111/j.1469-8749.2008.03021.x. PMID: 18611202.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Changes in User Satisfaction and Quality of Life Following 4 Weeks of Instrumented Standing Frame Intervention in Children With Disabilities - a Feasibility Intervention Study
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Aug 31, 2024
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: 4-week control period + 4-week intervention period

Prior to the intervention a 4-week control period, where the non-instrumented standing frame is used according to current practice, will be carried out. Subsequently, a 4-week intervention period, where the standing frame is instrumented (PONDUS®) allowing continued adjustments of the force and position within and between sessions will be conducted.

Device: PONDUS®
PONDUS® is a CE-marked medical device to support the positioning of the user in a R82 standing frame. PONDUS® is designed as a pair of instrumented foot plates and an app as an external display. PONDUS® gives individual readings from the right and the left plate telling how much force is applied to each plate by combining high frequency data from three pressure sensors in each plate. The data is displayed in the app as a time series graph and can also be exported.

Outcome Measures

Primary Outcome Measures

  1. Patient satisfaction with an instrumented standing frame [8 weeks difference in change score between the control period and intervention period]

    Patient satisfaction with an instrumented standing frame will be assessed with the Quebec User Evaluation of Satisfaction with Assistive Technology (Quest 2.0) questionnaires eight items assessing characteristics of the assistive device in terms of the following dimensions: 1) dimensions (size), 2. weight, 3. adjustments, 4. safety, 5. durability, 6. simplicity of use, 7. comfort and 8. effectiveness

Secondary Outcome Measures

  1. The three most important aspects of patient satisfaction with an instrumented standing frame [8 weeks difference in change score between the control period and intervention period]

    Through user involvement, the three key aspects of patient satisfaction with an instrumented standing frame will be selected from the Quebec User Evaluation of Satisfaction with Assistive Technology (Quest 2.0) questionnaire

  2. Usability of an instrumented standing frame [8 weeks difference in change score between the control period and intervention period]

    Usability of an instrumented standing frame will be assessed with the Usefulness, Satisfaction, and Ease of use (USE) Questionnaire

  3. Health-related quality of life [8 weeks difference in change score between the control period and intervention period]

    Health-related quality of life will be assessed with the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD) questionnaire

  4. Changes in prescription from the prescribing therapist [8 weeks difference in change score between the control period and intervention period]

    Changes in prescription from the prescribing therapist of the use of the standing frame when PONDUS® is applied opposed to current practice will be assessed with a self-constructed questionnaire made for the purpose

Other Outcome Measures

  1. Patient satisfaction with assistive device service of an instrumented standing frame [8 weeks difference in change score between the control period and intervention period]

    Patient satisfaction with assistive device service of an instrumented standing frame will be assessed with the Quebec User Evaluation of Satisfaction with Assistive Technology (Quest 2.0) questionnaires four items assessing characteristics of service in terms of the following dimensions: 1. service delivery, 2. repairs and service of the device, 3. professionalism of service and 4. follow-up service

  2. Patient satisfaction with PONDUS® [4 weeks score from the intervention period]

    Patient satisfaction with PONDUS® will be assessed with the Quebec User Evaluation of Satisfaction with Assistive Technology (Quest 2.0) questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children with disabilities aged 3-17 years who uses a standing frame

  • Informed consent from parents

  • Informed consent from children aged 15-17 years

Exclusion Criteria:
  • Earlier interventions in the form of orthopedic surgery within the past 52 weeks

  • Injections with botulinum toxin type A in the 12 weeks prior to baseline assessments

  • Insufficient co-operation and cognitive understanding to participate in the study

  • Planned interventions in form of orthopedic surgery and/or botulinum toxin type A in the study period

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Southern Denmark Odense C Denmark 5000

Sponsors and Collaborators

  • University of Southern Denmark
  • R82 A/S
  • Innovation Fund Denmark

Investigators

  • Principal Investigator: Anders Holsgaard-Larsen, Professor, Department of Clinical Research, SDU & Department of Orthopaedics and Traumatology, OUH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Southern Denmark
ClinicalTrials.gov Identifier:
NCT06033885
Other Study ID Numbers:
  • 11.928
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Southern Denmark

Study Results

No Results Posted as of Sep 13, 2023